Status:

RECRUITING

Family-Based Financial Incentives Intervention for Smoking Cessation

Lead Sponsor:

Mayo Clinic

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Alaska Native Tribal Health Consortium

Conditions:

Smoking Cessation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a con...

Detailed Description

Dyads will be stratified by the index participant's sex, and residence with family member, and by the family member's current smoking status then randomized to a no incentives control condition (n=328...

Eligibility Criteria

Inclusion

  • Index Participant
  • Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska.
  • Age ≥18 years.
  • Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team).
  • Smoked ≥ 3 cigarettes per day over the past 3 months.
  • Considering or willing to make a quit attempt.
  • Have or will nominate one adult family member to enroll with them.
  • Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration
  • Willing to upload photos of self during completion of smoking status tests.
  • Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study.
  • Willing to provide written informed consent and participate in study-related tests and procedures.
  • Index Participant

Exclusion

  • Used pharmacotherapy or a stop smoking program within the past 3 months.
  • Already enrolled in the study with another family member.
  • Self-report current marijuana smoking more than once per week and are not willing to quit for the study duration (interferes with breath test).
  • Participated in a prior study phase.
  • Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant):
  • Age ≥18 years.
  • Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting.
  • Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration.
  • Willing to complete and sign an IRS W-9 tax identification form if they wish to receive payments on the study.
  • Willing to provide written informed consent and participate in study related tests and procedures.
  • Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants.
  • Family Member Participant

Key Trial Info

Start Date :

September 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2028

Estimated Enrollment :

1312 Patients enrolled

Trial Details

Trial ID

NCT06556433

Start Date

September 3 2024

End Date

January 31 2028

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Alaska Native Tribal Health Consortium

Anchorage, Alaska, United States, 99508